Clinical Trial Update: Mepolizumab and In-office Nasal Polypectomy in Patients With Chronic Rhinosinusitis (CRS). A Three Arm Study. [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating mepolizumab in combination with in-office nasal polypectomy for chronic rhinosinusitis with polyps; status is currently unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis Chronic
• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• Mepolizumab (mepolizumab)

Snippet

Sponsor: Instituto de Investigación Marqués de Valdecilla | Conditions: Rhinosinusitis Chronic, Polyp, Nasal | Phase 4 | Status: UNKNOWN